Multi-center Study of Deep Learning AI in Breast Mass

NCT05443672 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1122

Last updated 2022-07-05

No results posted yet for this study

Summary

This multi-center study intends to evaluate the value of the detection and differential diagnosis of breast mass using deep learning AI-based real-time ultrasound examination.

Conditions

  • Breast Neoplasms

Interventions

DEVICE

Yizhun BUSMS

During the breast scanning, Yizhun BUSMS uses different color box to identify the breast lesion, and the box color indicates the risk grade of the lesion.

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER
  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Peking University Third Hospital

    collaborator OTHER
  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER
  • Third Affiliated Hospital of Zhengzhou University

    collaborator OTHER
  • Hebei Medical University Fourth Hospital

    collaborator OTHER
  • Henan Cancer Hospital

    collaborator OTHER_GOV
  • Shanxi Province Cancer Hospital

    collaborator OTHER
  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER
  • Chongqing University Cancer Hospital

    collaborator OTHER
  • Anqing Hospital affiliated to Anhui Medical University

    collaborator UNKNOWN
  • Qinhuangdao Maternal and Child Health Care Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Xiamen University

    collaborator OTHER
  • Anyang Tumor Hospital

    collaborator OTHER
  • The Third Affiliated Hospital of Jinzhou Medical University

    collaborator UNKNOWN
  • General Hospital of Jincheng Coal Industry Group

    collaborator UNKNOWN
  • Suzhou First People's Hospital

    collaborator UNKNOWN
  • Peking University

    collaborator OTHER
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Yong Wang · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-12
Primary Completion
2022-08-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05443672 on ClinicalTrials.gov